Images

Filter by

Figure 1 A Dot Plot Representation of the Relationship between PVC Burden and Ejection Fraction in 174 Patients Referred for PVC Catheter Ablation
Figure 1: A Dot Plot Representation of the Relationship between PVC Burden and Ejection Fraction in 174 Patients Referred for PVC Catheter Ablation
Table 3 Clinical Utility of Cardiovascular Magnetic Resonance Techniques Ordered by Pathophysiological Mechanism and Tissue Characteristics
Table 3: Clinical Utility of Cardiovascular Magnetic Resonance Techniques Ordered by Pathophysiological Mechanism and Tissue Characteristics
Figure 11 Number of Deaths of Patients with Thalassaemia Major in the UK
Figure 11: Number of Deaths of Patients with Thalassaemia Major in the UK
Table 2 T1 Mapping Studies in Heart Failure Populations
Table 2: T1 Mapping Studies in Heart Failure Populations
Table 1 T1 Mapping Studies in All comers for Cardiovascular Magnetic Resonance Extracellular Volume is used as the Parameter for All
Table 1: T1 Mapping Studies in All-comers for Cardiovascular Magnetic Resonance (Extracellular Volume is used as the Parameter for All)
Figure 10 Association between Extracellular Volume and Clinical Outcome per Left Ventricular Ejection Fraction
Figure 10: Association between Extracellular Volume and Clinical Outcome per Left Ventricular Ejection Fraction
Figure 9 Association of Cardiovascular Magnetic Resonance Parameters with All cause Mortality
Figure 9: Association of Cardiovascular Magnetic Resonance Parameters with All-cause Mortality
Figure 8 Multiparametric Cardiovascular Magnetic Resonance Tissue Characterisation
Figure 8: Multiparametric Cardiovascular Magnetic Resonance Tissue Characterisation
Figure 7 Diagnostic Utility of Tissue Characterisation using Native T1 and Extracellular Volume Fraction Based on MOLLI at 1 5T
Figure 7: Diagnostic Utility of Tissue Characterisation using Native T1 and Extracellular Volume Fraction (Based on MOLLI at 1.5T)
Figure 6 Five year Risk Estimates for Primary Sudden Cardiac Death and Aborted Sudden Cardiac Death Based on Left Ventricular Ejection Fraction Alone and Midwall Late Gadolinium Enhancement Status in Addition to Left Ventricular Ejection Fraction
Figure 6: Five-year Risk Estimates for Primary Sudden Cardiac Death and Aborted Sudden Cardiac Death Based on Left Ventricular Ejection Fraction Alone and Midwall Late Gadolinium Enhancement Status in Addition to Left Ventricular Ejection Fraction
Figure 5 Implantable Cardioverter Defibrillator Discharge and Sudden Cardiac Death Rates According to Ejection Fraction and Scar Burden
Figure 5: Implantable Cardioverter-Defibrillator Discharge and Sudden Cardiac Death Rates According to Ejection Fraction and Scar Burden
Figure 4 Clinical Outcome of Cardiac Resynchronisation Therapy According to Implantation Strategy
Figure 4: Clinical Outcome of Cardiac Resynchronisation Therapy According to Implantation Strategy